Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment Interruption

Given the widespread use of analytic treatment interruption in cure-related trials, these predictors may be useful to increase the safety of analytic treatment interruption through early identification of people who are unlikely to become posttreatment controllers.

Authors

Institutions

Publication Details

Journal
The Journal of Infectious Diseases
Published
2024-11-07
DOI
https://doi.org/10.1093/infdis/jiae551
Citations
3
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.88

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment Interruption

Bruce D. Walker, Michael C. Sneller, Gesham Magombedze, Susan J. Little et al.
3 citations
The Journal of Infectious Diseases
HIV Research and Treatment
0.88
article

Early Viral Dynamics Predict Human Immunodeficiency Virus Posttreatment Control After Analytic Treatment Interruption

Bruce D. Walker, Michael C. Sneller, Gesham Magombedze, Susan J. Little, Devi SenGupta, Frederick Hecht, Jonathan Z. Li, Jean‐Pierre Routy, Davey M. Smith, Michael J. Peluso, Elena Vendrame, Steven G. Deeks, Tae-Wook Chun, Romas Geleziunas
article en
3 citations

Abstract

Given the widespread use of analytic treatment interruption in cure-related trials, these predictors may be useful to increase the safety of analytic treatment interruption through early identification of people who are unlikely to become posttreatment controllers.

The Journal of Infectious DiseasesVol. 231(2)
Brigham and Women's Hospital (US), National Institutes of Health (US), Howard Hughes Medical Institute (US), Harvard University (US), University of California, San Francisco (US), McGill University Health Centre (CA), Ragon Institute of MGH, MIT and Harvard (US), University of California System (US), California Institute of Integral Studies (US), University of California San Diego (US), Massachusetts General Hospital (US), Gilead Sciences (United States) (US)
Gilead Sciences, National Institutes of Health, Instituto Nacional do Câncer, Ministério da Saúde, National Institute of Allergy and Infectious Diseases, NHLBI Division of Intramural Research
Good health and well-being
Openalex Percentile: Top 26%
HIV Research and Treatment
0.88
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.